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Summary.-N-Nitroso-N-methylurea (NMU) induced a marked dose dependent
leucopoenia which was associated with an increased survival of skin allografts in
adult rats and in 2 strains of mice. The humoral immune response to NMU as
assessed by haemolytic plaque formation and haemagglutination was also much
reduced. Dimethylnitrosamine (DMN) which, like NMU is a powerful carcinogen
and an alkylating agent, showed no immunosuppressive activity after a single dose
in rats on either a normal diet or fed a protein-free diet which enhances kidney
tumourigenesis. In mice DMN at a near LD50 dose (14 mg/kg) had no effect on skin
graft survival but did reduce the humoral response. At half this dose level, however,
no immunosuppressive effect was seen. The results support the conclusion that the
immunosuppressive activity of a chemical carcinogen is not necessarily associated
with the expression of its carcinogenicity.
A NUMBER of chemical carcinogens
show a positive correlation between their
capacity to depress the immune response
and their ability to induce tumour forma-
tion. Some carcinogenic hydrocarbons
(Malmgren, Bennison and McKinley, 1952;
Linder, 1962; Ball, Sinclair and McCarter,
1966; Stjernsward, 1967; Ball, 1970),
alkylating agents (Berenbaum, 1964; Doell,
DeVaux St Cyre and Grabar, 1967), and
urethane (Parmiani, Colnaghi and Della
Porta, 1969; Parmiani, 1970), have a
marked effect on the humoral antibody
and/or on the cell mediated immune
responses. Immunodepressed animals, re-
lative to normal controls, generally show a
higher incidence either of lymphomata or
of a number of other tumours originating
in non-lymphoreticular tissues (Nishizuka,
Nakakuki and Usui, 1965; Trainin et al.,
1967; Lappe, 1961; Stutman, 1969; Lappe
and Prehn, 1969, 1970). Although a causal
relationship between immunosuppression
and chemical carcinogenesis is suggested
by these results, other, particularly more
recent, evidence has caused such a relation-
ship to be questioned (see Discussion).
N-Nitroso-N-methylurea (NMU) and
N-dimethylnitrosamine (DMN) are power-
ful carcinogens in several animal species.
In the rat, tumour induction by DMN is
confined to the liver, kidney and, under
some circumstances, the lung while NMU,
under various conditions of dosage, is
carcinogenic for many tissues with the
notable exception of the liver (Magee and
Barnes, 1967). The acute toxicities of
these 2 compounds are different. Whereas
DMN is primarily hepatoxic, NMU pri-
marily damages haemopoietic and lym-
phoid tissue and the gastrointestinal
tract. These facts suggest that NMU
would have a greater immunosuppressive
activity than DMN and Leaver, Swann
and Magee (1969) have shown that NMU
induces leucopoenia in rats whereas DMN
does not decrease the white blood cell
(w.b.c.) count as determined in miceEFFECT OF NMU AND DMN IN RATS AND MICE
(Frei, 1970). Although there is some
information on the effect of NMU and
DMN on the humoral and cell mediated
immune responses in mice and rats (see
Parmiani et al., 1971; Scherf, 1972;
Denlinger et al., 1973) a systematic study
of both these responses in rats and mice
has not been carried out.
A remarkable point of similarity be-
tween NMU and DMN is shown by their
action in the kidney of the rat where both
compounds induce histologically similar
tumours in survivors of large doses (see
Leaver et al., 1969). Furthermore, there
is evidence that the extent of initial
interaction with cellular components in
the kidney, as measured by alkylation of
nucleic acids, is very similar for the two
compounds (Swann and Magee, 1968).
In this case therefore, kidney tumouri-
genesis would seem to offer a useful model
system for assessing the role of immuno-
depression by these 2 chemically related
carcinogens, which probably initiate carci-
nogenesis by the same mechanism.
MATERIALS AND METHODS
Carcinogens. NMU, which is unstable in
alkaline solution (Druckrey et al., 1967), was
dissolved in water containing a small amount
ofKH2PO4 to maintain acidity (about pH 5).
The carcinogen was completely dissolved
after about 30 min, during which time the
solution w%as kept stirred and in a darkened
container since NMU undergoes photo-
decomposition. Solutions were prepared
freshly for each experiment and were injected
with the minimum of delay. DMN was
dissolved in wiater before injection.
Skin grafting.-Adult male Wistar rats
from the Institute's closed colony were used
as recipients of inbred male BDIX rat skin.
Grafts of approximately 2-5 cm diameter and
minus their panniculus carnosus were placed
on suprapannicular graft beds prepared in
the lateral thoracic region of the recipient.
The grafts w%ere covered with " tulle gras "
and protected by a plaster of Paris bandage.
They were exposed 9 days later (day of
grafting = Day 0) and rejection was scored
when the grafts first appeared completely
mummified.
For mice, the technique of Keast (1968)
was used. Two full thickness punch grafts,
each 7 mm in diameter and obtained with a
heavy stationer's punch (Maun Industries
Ltd, Mansfield, Nottinghamshire) were ex-
changed between adult male (C57BL,3 x
BALB/Jc)F1 mice (designated F1) and
NMRI mice (i.e. 2 grafts per mouse). The
grafts were kept in place by a strip of Flexo-
plast medicated dressing and the area was
finally covered with several turns of elasti-
eated adhesive bandage. The dressings were
removed at 7 days and rejection was scored
as for rat skin grafts.
Haemnolytic plaque formiation.-An i.v.
injection of approximately 1 x 109 sheep red
blood cells (r.b.c.) was given on Day 1 to rats
and 4 x 107 r.b.c. on Day 2 to mice after
NMU, DMN and control treatments (on Day
0). Animals were killed on Day 6 and the
direct (1gM) plaque forming cells (PFC) in
their spleens were determined by the method
of Jerne, Nordin and Henry (1963). Pre-
served guinea-pig serum (Welleome Reagents
Ltd, Beckenham, Kent, England) was used
as the source ofcomplement.
Haemagglutinin titre. Sera wrere collected
from animals immunized with sheep r.b.c.
(see previously) and incubated at 56°C for
30 min to inactivate complement. To doub-
ling dilutions of sera in plastic trays, 0.500
sheep r.b.c. were added and the titre read as
the last dilution to shoN complete agglutina-
tion.
W.b.c. count. Blood was collected from
the tail into a w.b.c. pipette and stained
according to the propylene glycol dye method
of Randolph (1944). The count was read in
a Neubauer counting chamber.
Experimental procedures. NMU was ad-
ministered orally to groups of rats either as a
single dose on Day 0 or as 2 doses on Days 0
and 5. Each dose was 90 mg/kg body
weight. DMN was given orally as a single
dose of 40 mg/kg body Aweight which was the
approxiinate LD50 dose for the Wistar rats.
In one group, a protein-free diet Nas fed for
1 week before and 1 week following DMN
administration. Control rats wAere given
either 1 or 2 doses of very dilute KH2PO4
solution as used for dissolving the NMU, or
plain distilled water.
One or 2 doses of NMU at 50 mg/kg body
weight/dose were injected intraperitoneally
on Day 0 and Days 0 to 5 respectively into
one or both mouse strains. A third experi-
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mental group was given 10 daily i.p. injections
of 10 mg/kg (total 100 mg/kg). DMN was
given i.p. either as a single dose of 14 mg/kg
body weight, w%hich wtas near the LD50 dose
for both mouse strains, or as a single dose of
7 mg/kg. Matching control groups were also
prepared.
W.b.c. counts were obtained on Days
-1, 1, 6, 15 and on Day 4 in the control
mice and in the groups receiving 2 doses of
NMU. In addition, a further count was
obtained on Day 21 in the rat experiments.
In the skin grafting experiments, each
experiment was repeated at least once and
since the response patterns were similar the
results in each group wiere pooled and
reported as the arithmetic mean + s.e. The
humoral response tests are reported as the
geometric mean + s.e. However, because of
the nature of this s.e., it is displayed in
parenthesis in the Tables and shows the
effect of adding or subtracting one s.e. from
the log transformed values. The differences
between means were analysed either by the
standard t-test or bytheWilcoxon two-sample
rank test.
RESULTS
The results from all skin grafted control
groups were similar and therefore were
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pooled. In those groups of both rats and
mice receiving 2 or more doses of NMU,
some animals died with viable skin grafts.
Such animals were included in the results
and the day of death was used in the
assessment of the mean survival time
(MST) of the grafts. It is explicit there-
fore that in these groups the true survival
times are higher than those quoted in the
results.
Skin grafting; w.b.c. counts
Rats.-Figure 1 shows the w.b.c.
count and MST in control and DMN
treated animals. There was a leucocytosis
between Day 1 and Day 6 in the control
group, possibly associated with the skin
grafting, but little variation thereafter.
The MST of the grafts was 11-3 ± 0u2
days. In the DMN treated rats the initial
leucocytosis was marked. The count had
decreased by Day 15 and all animals
subsequently died by Day 21, reflecting
the toxicity of the dose of DMN and
possibly the stress of the earlier allograft
rejection. No leucopoenia was seen at
any time and skin graft survival was
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similar to that of the controls (MST,
10-8 ± 0-3 days).
The results of NMU treatment are
shown in Fig. 2. Rats treated with a
single dose of NMU showed a significant
drop in w.b.c. count by 24 h and a marked
leucopoenia by the sixth day. Normal
counts had returned by Day 15. The
MST for the skin grafts was 12-8 ± 0-5
days, which was a small but significant
increase over the controls (P < 0.01).
Two doses of NMU produced a very
marked and progressive leucopoenia by
Day 6 which was sustained to Day 15.
The one remaining rat at Day 21 had a
normal count. The MST was 15-7 ± 1-0
days, which was a significant increase
over that for rats dosed only once
(P < 0-02).
Mice.-The response patterns between
the rat and mouse experiments and
between the 2 strains ofmice were remark-
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ably similar (Fig. 3, 4). The control mice
showed an initial leucocytosis and respec-
tive MST for the skin grafts ofthe F1 and
NMRI mice were 8-0 ± 0 and 8*3 + 0*3
days. DMN treatment produced results
comparable with those of the controls
although there was no post-grafting rise
in the w.b.c. count. NMU produced
marked leucopoenia which was prolonged
after 2 doses. Skin graft survival was
prolonged in both groups with signifi-
cantly longer survival for the F1 mice in
the group receiving 2 doses of the carci-
nogen. Mice receiving 10 mg/kg daily
showed no drop in w.b.c. count at 24 h
but the effect ofdaily dosage was accumu-
lative and became similar to that after 2
doses of 50 mg/1g. The MST for grafts in
both mouse strains was about double that
of the control groups (F1, 16-4 + 1-6;
NMRI, 16-5 ± 2-1 days).
PFC determination
Rats (Tables I, JJ).-A single oral dose
of NMU depressed the number of spleen
PFC to about 4% of the control value
when considered on a whole organ basis.
On the basis of the number of PFC/106
nucleated spleen cells, however, the differ-
ence from control was not significant.
This was due to a reduction in spleen size
and highlights the possible danger of
reporting results only on a " PFC per 106
cells " basis when immunosuppressive
activity of cytotoxic chemicals is being
studied. Two doses of NMU appeared to
produce a further fall in PFC. In con-
trast, DMN increased the number of
PFC/spleen in normal rats. A protein-free
diet alone induced a marked fall in the
number of PFC but treatment of these
animals with DMN did not produce any
further reduction.
Mice (Table III).-NMU reduced the
number of PFC in F1 mice and a fall also
was seen after treatment with an LD50
dose of DMN. However, the 7 mg/kg
dose produced no effect that was different
from the controls.
Haemagglutinin determination
Rats (Tables IV, V).-NMU markedly
reduced the circulating haemagglutinin
antibody titre. Although DMN produced
a fall in titre this was not significantly
different from the control. (This was
confirmed by several repeat experiments-
H. B. Waynfqrth, unpublished work.)
DMN did not further reduce the fall in
titre induced by feeding rats a protein-free
diet.
Mice (Table VI).-Both NMU and
DMN at the 14 mg/kg dose level induced
a fall in antibody titre. Again, for DMN
there was no effect at the 7 mg/kg dose.
DISCUSSION
The increased skin graft survival time
in both rats and mice treated with NMU
showed some dose dependency and was
apparently related to the length of the
immunodepressed state and possibly the
degree of immunodepression as reflected
by the fall in the number of circulating
leucocytes. This leucopoenia represents a
generalized fall in all the w.b.c. elements
but is more marked for lymphocytes (Frei,
1970; H. B. Waynforth, unpublished
results). DMN produced neither extended
graft survival nor a reduction in the w.b.c.
count despite the high toxic dose used.
The skin grafting experiments involved
the use of animals showing strong histo-
compatibility differences, as indicated by
the prompt rejection of control skin
grafts. This indication of a strong
immunodepressive potency for NMU is in
contrast to the findings for 2 extensively
studied carcinogens, urethane (Lappe and
Steinmuller, 1970; Parmiani, 1970) and
3-methylcholanthrene (Linder, 1962;
Stjernsward, 1965) and for carcinogenic
hydrocarbons in general. The immuno-
depression induced by these compounds
was of a lower relative potency since it
was associated with survival of grafts
only from donors showing a weak histo-
compatibility difference (i.e. isogenic
grafting of skin from male donors onto
female recipients).
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TABLE III.-Determination ofPFC in Spleens ofF1 Mice Treated i.p. with
NMU and DMN
Day of No. of
Treatment treatment mice Mean PFC/Spleen + s.e. (103) P*
Control lt 0&5 5 53-48(67 02-42 67)
NMU 1.
50mg/kg 0 5 2.62(3.16-2.17) <0.001
NMU 1.
50mg/kg 0 & 5 5 0 43 (0 48-0-38) <0.001
2.
<0.001
Control2t 0 5 90-65(104 65-7875)
DMN
1.
14mg/kg 0 8 10-41 (16-93-6-40) <0-01
DMN
1.
7mg/kg 0 6 146-99(166 64-129-66) <0*05
2.
<0 001
* Pvs 1. Appropriate control; 2. Other NMU or DMN group.
t Control =- control to NMU groups; Control 2 = control to DMN groups.
TABLE IV.-Anti-sheep r.b.c. Haemagglutinin Titre in Rats Treated Orally
with NMU and DMN
Day of No. of
Treatment treatment rats Mean haemagglutinin titre + s.e. P*
Control 0 5 294-07 (412 97-209*40)
NMU
1.
90mg/kg 0 5 12-13(19*40-7*38) <0*001
NMU 1.
90mg/kg 0 &5 4 26-91(41.62-17.40) <0-01
2. NS
DMN
40mg/kg 0 13 135-01 (167-29-108-96) 1. NS *P vs 1. Control; 2. NMU-one dose; NS = Not significant.
TABLE V.-Anti-sheep r.b.c. Haemagglutinin Titre in Rats Fed a Protein-free
Diet and Treated with a Single Oral Dose of DMN
No. of
Treatment rats Mean haemaggltutinin titre ± s.e.
Control 8 789 61 (1024 00-608- 87)
1.
Protein-free diet 10 238-86 (343-93-165. 88) 0 02
Protein-free diet +
DMN 40mg/kg 14 141-32 (187-00-106 80) <0-001
2. NS
* P vs 1. Control; 2. Protein-free diet; NS = Not significant.
TABLE VI.-Anti-sheep r.b.c. Haemagglutinin Titre inF1 Mice Treated i.p.
with NMU and DMN
Day of No. of Mean haemagglutinin
Treatment treatment mice :tre + s.e. P* Control 0 5 97 01 (155-23-60.62)
NMU 1.
50mg/kg 0 6 20- 16(23-33-17-42) <0- 01 NMIU 1.
50mg/kg 0 &5 6 12770 (14-70-10-97) <0- 01
0050
DMN 1.
14mg/kg 0 20 30 91 (37.43-25 53) 0-02 DMN 1. NS 7 mg/kg 0 6 9-51(105-68-77.51) 2.
* P vs 1. Control; 2. Other NMU or DMN grouip; NS Not significant.
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The strongly reduced humoral im-
mune response to NMU in both species is
in accord with the findings of Parmiani
et al. (1971) for newborn mice. DMN, on
the other hand, showed either no effect or
was immunostimulatory in the rat and at
the 7 mg/kg dose in mice, a dose level
shown by Den Engelse, Bentvelzen and
Emmelot (1970) to induce a high incidence
of lung tumours after intraperitoneal
injection in this species. Also a smaller
dose given to mice in their drinking water
for one week was shown to be an effective
carcinogenic stimulus (Terracini et al.,
1966). This finding of a lack of immuno-
suppressive actionforDMNisstrengthened
by its lack of effect also in rats fed a
protein-free diet, a procedure used by
Swann and Maclean (1968) to increase
greatly the yield of kidney tumours.
Whereas only 20% ofrats on a normal diet
get kidney tumours (Magee and Barnes,
1962), this is increased to 100% on feeding
a protein-free diet. Swann and Maclean
(1968) suggest that this increased tumour
incidence is due to a decreased meta-
bolism of DMN by the liver and an
increased alkylation ofthe nucleic acids of
the kidney. The present results indicate
that a third factor, a reduced immuno-
logical response, may possibly be involved.
Although a single carcinogenic dose of
DMN is without effect on the immune
system, an immunodepressive action for
this carcinogen in the form of a reduced
haemolytic plaque formation has been
shown by Scherf (1972) after its conti-
nuous long-term administration in
drinking water. The possibility, however,
that this activity may be due to ancillary
factors related to the mode and lengthi of
administration, such as a possible inter-
ference with normal nutrition, should be
taken into account.
The apparent inability of DMN, an
extremely powerful carcinogen, to affect
the immune system particularly in the rat
makes this compound one of the very few
chemical carcinogens without immuno-
suppressive activity at strongly carcino-
genic doses. Since others have also
concluded that some carcinogenic activity
can occur in the absence of immuno-
suppression (Prehn, 1963; Berenbaum,
1964; Stutman, 1969, 1974; Carbone and
Parmiani, 1971), it follows that such
activity is not a prerequisite for the
expression of carcinogenicity by chemical
carcinogens. Nevertheless, since most
chemical carcinogens do interfere with the
immune system, in a nonspecific manner, it
still remains of interest to explore the
possibility that this can potentiate their
inherent carcinogenicity.
Although both NMU and DMN share
the kidney as a common target organ, it
seems unlikely that the immunodepressive
activity of NMU plays a role in kidney
tumourigenesis by single doses of this
compound. This is because both the
incidence of tumours and the extent of
cellular interaction produced by NMU in
the rat are very similar to that produced
by DMN which has been shown in the
present work to be non-immunosuppres-
sive. Denlinger et al. (1973) reported that
in rats immunosuppressed by antilympho-
cyte serum (ALS), the incidence of NMU
induced neurogenic tumours was not
different from that in non-immunosup-
pressedcontrol animals. However, bladder
tumours were found only in the NMU
treated, ALS immunosuppressed rats,
suggesting a role for immunosuppression
in the appearance of tumours of this
particular organ. Hicks and Wakefield
(1972) showed that rats treated with 4
intravesicular doses of NMU injected at
2-week intervals, but not those treated
with only a single dose, developed papillo-
mata and transitional cell tumours of the
bladder. No immunological data were
obtained on these animals but the results
of Denlinger et al. (1973) raise the possi-
bilities of a contribution of immuno-
suppression, in this case induced by NMU
itself, to the production of these bladder
tumours.
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